Profile of Multi Drug Resistant Tuberculosis (MDR-TB) Patients Using Anti-TB Drugs in the Outpatient Unit of RSUD Poso Year 2022

Ajeng Kurniati Roddu; Suherman Baharuddin; Nur Aini Amir

doi:10.55927/ijsmr.v2i7.10382

Authors

Ajeng Kurniati Roddu East Indonesia University
Suherman Baharuddin East Indonesia University
Nur Aini Amir Poso Regional General Hospital

DOI:

https://doi.org/10.55927/ijsmr.v2i7.10382

Keywords:

Profile, MDR-TB, Patients, Anti-TB, RSUD Poso

Abstract

The purpose of this study was to determine and further examine the description of Multi Drug Resistant Tuberculosis (MDR-TB) patients who have used anti-tuberculosis drugs in the Poso Regional General Hospital outpatient unit. This type of research is a non-experimental descriptive study (retrospective in nature) using research instruments in the form of data collection (prescriptions or medical records) of outpatient MDR-TB patients at the Poso Regional General Hospital, Central Sulawesi in 2022. Based on the results of research that has been conducted in the period January - December 2022, it can be concluded that the characteristics of treatment in Tuberculosis patients as a whole are 226 people, there are patients with MDR-TB drugs 16 people (7.08%), with a total of 127 prescription sheets (11.28%), the potential for drug interactions 36 prescriptions (28.35%) and no interactions 91 prescriptions (71.65%). Types of opportunistic infections are with a history of diabetes mellitus (DM) 6 people (37.50%), comorbid kidney and liver disease 2 people (12.50%), HIV-AIDS disease 2 people (12.50%), pneumonia 5 people (31.25%), fungal infection 1 person (6.25%). The average use of MDR-TB drugs with more than 1 type of drug will produce drug side effects on initial therapy and continued therapy with a total of 14 cases (87.50%) with different drug side effects and 2 people (12.50%) who did not experience drug side effects

Downloads

Download data is not yet available.

References

Agarwal, S. G., Powar, R. M., Tankhiwale, S., & Rukadikar, A. (2015). Study of Opportunistic Infections in HIV-AIDS Patients and their Co-Relation with CD4+Cell Count. Int.J.Curr.Microbiol.App.Sci, 4(6), 848–861.

BLUD Poso. (2021). Rumah Sakit Umum Daerah Poso ; Rencana Bisnis Anggaran Perubahan Tahun 2021 (p. 30). Palu, Sulawesi Tengah.

Fitriani, D., Pratiwi, R. D., & Betty. (2020). Buku Ajar; TBC, Askep dan Pengawasan Minum Obat Dengan Media Telepon (M. Ns. Betty, S.Kep. (ed.)). STIKes Widya Dharma Husada Tangerang.

Framasari, D. A., Flora, R., & Sitorus, R. J. (2020). Infeksi Oportunistik Pada ODHA (Orang Dengan HIV/AIDS) Terhadap Kepatuhan Minum ARV (Anti Retroviral) Di Kota Palembang. Jambi Medical Journal “Jurnal Kedokteran Dan Kesehatan,” 8(1), 67–74. https://doi.org/10.22437/jmj.v8i1.9374

Handayani, R. S., Gitawati, R., Muktiningsih, S. ., & Raharni. (2006). Eksplorasi Pelayanan Informasi Yang Dibutuhkan Konsumen Apotek Dan Kesiapan Apoteker Memberi Informasi Terutama Untuk Penyakit Kronik Dan Degeneratif. Majalah Ilmu Kefarmasian, 3(1), 38–46.

Jiménez-Corona, M. E., García-García, L., DeRiemer, K., Ferreyra-Reyes, L., Bobadilla-Del-Valle, M., Cano-Arellano, B., Canizales-Quintero, S., Martínez-Gamboa, A., Small, P. M., Sifuentes-Osornio, J., & Ponce-De-León, A. (2006). Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax, 61(4), 348–353. https://doi.org/10.1136/thx.2005.049452

Kementerian Kesehatan RI. (2011). Pedoman Nasional Pengendalian Tuberkulosis (p. 99). Direktur Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan.

Kementerian Kesehatan RI. (2014). Petunjuk Teknis Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat (p. 166). Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan.

Kementerian Kesehatan RI. (2020). Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024. In Pertemuan Konsolidasi Nasional Penyusunan STRANAS TB (p. 216). Direktur Jenderal Pencegahan dan Pengendalian Penyakit.

Kementerian Kesehatan RI. (2023). Laporan Program Penanggulangan Tuberkulosis Tahun 2022 (pp. 1–156). Direktorat Pencegahan dan Pengendalian Penyakit Menular.

Khutsiyah, L., Sugihantoro, H., & Atmaja, R. R. D. (2018). Potensi Interaksi Obat Pada Pasien Tuberkulosis Paru Rawat Jalan Di RSUD Dr. Soegiri Lamongan Periode 2017 (p. 138). Jurusan Farmasi, Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Islam Negeri Maulana Malik Ibrahim Malang.

Komalasari, W. (2020). Analisis Penatalaksanaan Program Pengendalian Tuberkulosis Multi Drug Resistant (TB MDR) Di Puskesmas Bandarharjo Kota Semarang (p. 179). Jurusan Ilmu Kesehatan Masyarakat, Fakultas Ilmu Keolahragaan, Universitas Negeri Semarang.

Menteri Kesehatan RI. (2016). Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016 Tentang Penanggulangan Tuberkulosis (p. 163). Jakarta. Indonesia.

Munir, S. M., Nawas;, A., & Soetoyo;, D. K. (2010). Pengamatan Pasien Tuberkulosis Paru dengan Multidrug Resistant (TB-MDR) di Poliklinik Paru RSUP Persahabatan. Jurnal Respirologi Indonesia, 30(2), 92–104.

Musthofa, L. A. (2018). Evaluasi Drug Related Problems Kategori Dosis Berlebih, Subdosis, Dan Interaksi Obat Pada Pasien Tuberculosis Multi Drug Di Rawat Inap RSUD Dr. Moewardi Tahun 2017 (p. 21). Program Studi Farmasi, Fakultas Farmasi, Universitas Muhammadiyah Surakarta.

Nugrahaeni, D. K., & Malik, U. S. (2015). Analisis Penyebab Resistensi Obat Anti Tuberkulosis. Jurnal Kesehatan Masyarakat, 11(1), 8–15.

Reviono, Kusnanto, P., Eko, V., Pakiding, H., & Nurwidiasih, D. (2014). Multidrug Resistant Tuberculosis (MDR-TB): Tinjauan Epidemiologi dan Faktor Risiko Efek Samping Obat Anti Tuberkulosis. Majalah Kedokteran Bandung, 46(4), 189–196. https://doi.org/10.15395/mkb.v46n4.336

Sarwani, D., Nurlaela, S., & Isnani, Z. A. (2013). Analisis Faktor Risiko Multidrug Resistant Tuberculosis (MDR-TB)(Studi Kasus di BP4 Purwokerto). JKM, 8(1), 62–68.

Somasundaram, S., Ram, A., & Sankaranarayanan, L. (2014). Isoniazid and Rifampicin as Therapeutic Regimen in the Current Era: A Review. Journal of Tuberculosis Research, 02(01), 40–51. https://doi.org/10.4236/jtr.2014.21005

Tiffany, C. (2016). Studi Penggunaan Antituberkulosis pada Pasien AIDS Rawat Inap dengan Tuberkulosis paru. In ADLN- Perpustakaan Universitas Airlangga (pp. 110–112). Departemen FarmasiI Klinis, Fakultas Farmasi Universitas Airlangga.

WHO. (2010). Multidrug and extensively drug-resistant TB (M/XDR-TB) ; 2010 Global Report On Surveillance And Response (p. 71). World Health Organization Library.

WHO. (2014). Global Tuberculosis Report 2014 (p. 171). World Health Organization Library.

WHO. (2016). Global Tuberkulosis Report 2016 (p. 130). World Health Organization Library.

Wijaya, A. S., & Putri, Y. M. (2013). KMB 2 Keperawatan Medikal Bedah Dewasa Teori & Contoh Askep. Yogyakarta: Nuha Medika.

Yuniar, I., Sari, K. P., & Yudha, H. T. (2017). Analisa Situasi Tuberkulosis (TB) Di Kabupaten Kebumen. Jurnal Ilmiah Kesehatan Keperawatan, 13(1), 42–51.